Page last updated: 2024-08-24

pazufloxacin and moxifloxacin

pazufloxacin has been researched along with moxifloxacin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Arakawa, Y; Kato, H; Kimura, K; Konda, T; Shibata, N; Shibayama, K; Suzuki, S; Wachino, J; Yamane, K1
Drlica, K; German, N; Kerns, RJ; Malik, M; Marks, KR; Schwanz, HA1
Brady, SF; Koirala, B; Peek, J1
Baiza-Durán, L; Casillas-Magallanes, M; Gómez-Bastar, PA; González-Lomelí, M; Lizárraga-Corona, A; Mercado-Sesma, AR; Montoya-Sánchez, IM; Mora-González, A; Ochoa-Tabares, JC; Olvera-Montaño, O; Oregon-Miranda, AA; Orozco-Carroll, M; Páez-Garza, JH; Pérez-Balbuena, AL; Sandoval-Delgadillo, LI; Saucedo-Rodríguez, LR; Villanueva-Najera, MA1

Trials

1 trial(s) available for pazufloxacin and moxifloxacin

ArticleYear
Efficacy and Safety of 0.6% Pazufloxacin Ophthalmic Solution Versus Moxifloxacin 0.5% and Gatifloxacin 0.5% in Subjects with Bacterial Conjunctivitis: A Randomized Clinical Trial.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2018, Volume: 34, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Conjunctivitis, Bacterial; Double-Blind Method; Fluoroquinolones; Gatifloxacin; Haemophilus influenzae; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Ophthalmic Solutions; Oxazines; Staphylococcus; Young Adult

2018

Other Studies

3 other study(ies) available for pazufloxacin and moxifloxacin

ArticleYear
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:9

    Topics: Amino Acid Sequence; Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chitosan; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Malates; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Transformation, Bacterial; Uncoupling Agents

2007
Effect of N-1/c-8 ring fusion and C-7 ring structure on fluoroquinolone lethality.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12

    Topics: Anti-Infective Agents; Chloramphenicol; Escherichia coli; Fluoroquinolones; Levofloxacin; Ofloxacin; Oxazines; Structure-Activity Relationship

2010
Synthesis and evaluation of dual-action kanglemycin-fluoroquinolone hybrid antibiotics.
    Bioorganic & medicinal chemistry letters, 2022, 02-01, Volume: 57

    Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Escherichia coli; Fluoroquinolones; HEK293 Cells; Humans; Microbial Sensitivity Tests; Rifamycins; Staphylococcus aureus

2022